MEK and ERK inhibitors enhance the antiproliferative effect of interferon‐α2b
Open Access
- 21 August 2002
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 16 (12), 1680-1682
- https://doi.org/10.1096/fj.02-0120fje
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Molecular mechanisms underlying interferon-α-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteinsOncogene, 1999
- ERK Pathway Mediates the Activation of Cdk2 in IGF-1–Induced Proliferation of Human Osteosarcoma MG-63 CellsJournal of Bone and Mineral Research, 1999
- Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cellsOncogene, 1998
- DIFFERENTIAL SIGNALING BY LYMPHOCYTE ANTIGEN RECEPTORSAnnual Review of Immunology, 1997
- Malignant Glioma Sensitivity to Radiotherapy, High-dose Tamoxifen, and Hypericin: Corroborating Clinical Response in Vitro: Case ReportNeurosurgery, 1996
- Blocked Ras Activation in Anergic CD4 + T CellsScience, 1996
- Blocked Signal Transduction to the ERK and JNK Protein Kinases in Anergic CD4 + T CellsScience, 1996
- PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in VivoJournal of Biological Chemistry, 1995
- Requirement for MAP Kinase (ERK2) Activity in Interferon α- and Interferon β-Stimulated Gene Expression Through STAT ProteinsScience, 1995
- Transformation of Mammalian Cells by Constitutively Active MAP Kinase KinaseScience, 1994